Related Experiment Videos
Acquired pure red cell aplasia--a case report.
J Rahman1, M A Rashid, A B Yunus
1Department of Haematology, Bangabandhu Sheikh Mujib Medical University, Dhaka.
Bangladesh Medical Research Council Bulletin
|June 30, 2000
Summary
Systemic lupus erythematosus (SLE) can cause pure red cell aplasia, a rare anemia. Immunosuppressive therapy effectively treated this patient's condition, suggesting an immune basis for SLE-related red cell aplasia.
Area of Science:
- Hematology
- Immunology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Pure red cell aplasia (PRCA) is a rare anemia characterized by the selective absence of erythroid precursors in the bone marrow.
- PRCA can have autoimmune etiologies, but its association with SLE is infrequently reported.
Observation:
- A 36-year-old female patient presented with chronic anemia, hypothyroidism, and was diagnosed with SLE.
- The anemia was identified as PRCA with a hemolytic component.
- The patient had hypothyroidism secondary to antithyroid autoantibodies.
Findings:
- Treatment with corticosteroids and immunosuppressive agents led to the correction of the patient's anemia.
- The positive response of PRCA to immunosuppressive therapy in this SLE patient suggests an immune-mediated pathogenesis.
- This case highlights the potential role of immunological factors in the development of PRCA within the context of SLE.
Implications:
- The findings support the concept that PRCA in SLE may be of immune etiology.
- This case underscores the importance of considering PRCA in SLE patients presenting with unexplained anemia.
- Effective management of PRCA in SLE may involve targeted immunosuppressive therapies.